Wu Junwan相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Optimal Adjuvant Therapy Selection for Chinese BRAF V600-Mutant Stage III Melanoma: A Multicenter Efficacy Comparison of Targeted Agents, Immunotherapy, and Combinatorial Strategies

中国BRAF V600突变型III期黑色素瘤最佳辅助治疗方案选择：靶向药物、免疫疗法和联合治疗策略的多中心疗效比较

影响因子:10.7

doi:10.1002/mco2.70738

Zhang, Rongcheng; Liang, Yao; Li, Jingjing; Chen, Qianqi; Ding, Ya; Wen, Xizhi; Zhao, Baiwei; Zheng, Wei; Wu, Junwan; Zhang, Qiong; Chen, Ziluan; Ding, Qiuyue; Chen, Linbin; Li, Renai; Li, Ke; Zhou, Qiming; Zhang, Xiaoshi; Li, Dandan

免疫/内分泌

发表日期：2026

文献求助收藏

Combination of Postoperative Adjuvant Chemoradiotherapy and Immune Checkpoint Inhibitors Significantly Prolongs Recurrence-Free Survival in Sinonasal Mucosal Melanoma

术后辅助放化疗联合免疫检查点抑制剂可显著延长鼻窦黏膜黑色素瘤患者的无复发生存期

期刊:Journal of Otolaryngology-Head & Neck Surgery

影响因子:2.2

doi:10.1177/19160216251414150

Ding, Qiuyue; Wu, Junwan; Ding, Ya; Li, Dandan; Wen, Xizhi; Jiang, Hang; Chen, Linbin; Zhang, Qiong; Zhang, Yuan; Lu, Lixia; Zhang, Xiaoshi; Li, Jingjing

免疫/内分泌

发表日期：2026

文献求助收藏

Addition of anti-PD-1 immunotherapy to BRAF inhibitor-based targeted therapy improves real-world survival and delays brain metastases in patients with BRAF(V600)-mutant advanced melanoma: a multicenter cohort study

在BRAF抑制剂靶向治疗的基础上加用抗PD-1免疫疗法可改善BRAF(V600)突变型晚期黑色素瘤患者的真实世界生存期并延缓脑转移：一项多中心队列研究

影响因子:10.7

doi:10.1002/mco2.70102

Wu, Junwan; Ding, Qiuyue; Zhang, Qiong; Chen, Qianqi; Wen, Xizhi; Ding, Ya; Li, Jingjing; Chen, Ziluan; Zhang, Tao; Wang, Jiuhong; Huang, Fuxue; Jiang, Hang; Chen, Linbin; Zhou, Qiming; Li, Ke; Zhang, Xiaoshi; Li, Dandan

免疫/内分泌

发表日期：2025

文献求助收藏

Natural Killer Cell Activation Signature Identifies Cyclin B1/CDK1 as a Druggable Target to Overcome Natural Killer Cell Dysfunction and Tumor Invasiveness in Melanoma.

自然杀伤细胞激活特征表明细胞周期蛋白 B1/CDK1 可作为药物靶点，以克服黑色素瘤中自然杀伤细胞功能障碍和肿瘤侵袭性

期刊:Pharmaceuticals

影响因子:4.8

doi:10.3390/ph18050666

Chen Linbin, Liao Wanqian, Huang Jing, Ding Qiuyue, Wu Junwan, Zhang Qiong, Ding Ya, Li Dandan, Li Jingjing, Wen Xizhi, Zhang Xiaoshi

发表日期：2025

文献求助收藏

Comprehensive pan-cancer analysis of mitochondrial outer membrane permeabilisation activity reveals positive immunomodulation and assists in identifying potential therapeutic targets for immunotherapy resistance

对线粒体外膜通透性活性的全面泛癌分析揭示了其积极的免疫调节作用，并有助于识别免疫治疗耐药性的潜在治疗靶点。

期刊:Clinical and Translational Medicine

影响因子:6.8

doi:10.1002/ctm2.1735

Chen, Qingshan; Gao, Fenglin; Wu, Junwan; Zhang, Kaiming; Du, Tian; Chen, Yuhong; Cai, Ruizhao; Zhao, Dechang; Deng, Rong; Tang, Jun

免疫/内分泌

发表日期：2024

文献求助收藏